Robin Gross
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Neurology top 10%
- Peripheral Neuropathies and Disorders
- Long-Term Effects of COVID-19
Papers in
-
- SARS-CoV-2 and COVID-19 Research 6
- Viral Infections and Outbreaks Research 6
- COVID-19 Clinical Research Studies 2
- Co-authors
- Peter B. Jahrling (6 shared papers)Lisa E. Hensley (5 shared papers)Julie Dyall (5 shared papers)Matthew B. Frieman (2 shared papers)Gene G. Olinger (4 shared papers)Reed F. Johnson (4 shared papers)Jason Kindrachuk (1 shared paper)Robert Safirstein (1 shared paper)
- Journals
- The Journal of Infectious Diseases (2 papers)Viruses (2 papers)PLoS ONE (2 papers)Nature Communications (1 paper)Drugs (1 paper)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Robin Gross
15 papers receiving 588 citations
Peers
Comparison fields: 5 of 106
- Infectious Diseases 227
- Neurology 103
- Biological Psychiatry 9
- Oncology 95
- Modeling and Simulation 17
Countries citing papers authored by Robin Gross
This map shows the geographic impact of Robin Gross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Gross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Gross more than expected).
Fields of papers citing papers by Robin Gross
This network shows the impact of papers produced by Robin Gross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Gross. The network helps show where Robin Gross may publish in the future.
Co-authors
The 25 scholars most cited alongside Robin Gross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 147 | |
| 2 | Inhibition of amino acid transport by cis-diamminedichloroplatinum(II) derivatives in L1210 murine leukemia cells. | 1983 | 98 |
| 3 | 2018 | 81 | |
| 4 | 1981 | 72 | |
| 5 | 1972 | 56 | |
| 6 | 2021 | 41 | |
| 7 | 2019 | 34 | |
| 8 | 2018 | 33 | |
| 9 | 2018 | 22 | |
| 10 | 2006 | 20 | |
| 11 | 2021 | 14 | |
| 12 | 2021 | 13 | |
| 13 | 2021 | 6 | |
| 14 | 2020 | 5 | |
| 15 | 1984 | 3 | |
| 16 | 2006 | 0 |
About Robin Gross
Robin Gross is a scholar working on Infectious Diseases, Immunology, Animal Science and Zoology, Genetics and Biomedical Engineering, having authored 16 papers that have together received 645 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), Viral Infections and Outbreaks Research (6 papers), COVID-19 Clinical Research Studies (2 papers), Virus-based gene therapy research (2 papers), Respiratory Support and Mechanisms (1 paper), Virology and Viral Diseases (1 paper), COVID-19 epidemiological studies (1 paper) and Copyright and Intellectual Property (1 paper). The work is most often cited by research in Infectious Diseases (227 citations), Neurology (103 citations), Biological Psychiatry (9 citations), Oncology (95 citations) and Modeling and Simulation (17 citations). Robin Gross has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Peter B. Jahrling, Lisa E. Hensley, Julie Dyall, Matthew B. Frieman, Gene G. Olinger, Reed F. Johnson, Jason Kindrachuk, Robert Safirstein, Kevin J. Scanlon and Joseph B. Guttenplan. Their work appears in journals such as The Journal of Infectious Diseases, Viruses, PLoS ONE, Nature Communications and Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.